BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18532966)

  • 1. Triage of ovarian masses.
    Chia YN; Marsden DE; Robertson G; Hacker NF
    Aust N Z J Obstet Gynaecol; 2008 Jun; 48(3):322-8. PubMed ID: 18532966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative evaluation and triage of women with suspicious adnexal masses using risk of malignancy index.
    Enakpene CA; Omigbodun AO; Goecke TW; Odukogbe AT; Beckmann MW
    J Obstet Gynaecol Res; 2009 Feb; 35(1):131-8. PubMed ID: 19215560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol.
    Van Calster B; Timmerman D; Valentin L; McIndoe A; Ghaem-Maghami S; Testa AC; Vergote I; Bourne T
    BJOG; 2012 May; 119(6):662-71. PubMed ID: 22390753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of intraoperative frozen section in the diagnosis of ovarian tumors.
    Yarandi F; Eftekhar Z; Izadi-Mood N; Shojaei H
    Aust N Z J Obstet Gynaecol; 2008 Aug; 48(4):438-41. PubMed ID: 18837853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of laparoscopy in the diagnosis and treatment of adnexal masses.
    Leng JH; Lang JH; Zhang JJ; Feng FZ; Liu ZF; Sun DW; Zhu L; Zhao XY
    Chin Med J (Engl); 2006 Feb; 119(3):202-6. PubMed ID: 16537005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
    Booth SJ; Turnbull LW; Poole DR; Richmond I
    BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.
    Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C;
    Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The accuracy of intraoperative frozen sections in the diagnosis of ovarian tumors.
    Wasinghon P; Suthippintawong C; Tuipae S
    J Med Assoc Thai; 2008 Dec; 91(12):1791-5. PubMed ID: 19133510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
    Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population.
    Ong C; Biswas A; Choolani M; Low JJ
    Singapore Med J; 2013 Mar; 54(3):136-9. PubMed ID: 23546025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?
    Yavuzcan A; Caglar M; Ozgu E; Ustun Y; Dilbaz S; Ozdemir I; Yildiz E; Gungor T; Kumru S
    Asian Pac J Cancer Prev; 2013; 14(9):5455-9. PubMed ID: 24175841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.
    Moolthiya W; Yuenyao P
    Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases?
    Bailey J; Tailor A; Naik R; Lopes A; Godfrey K; Hatem HM; Monaghan J
    Int J Gynecol Cancer; 2006; 16 Suppl 1():30-4. PubMed ID: 16515564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting.
    Manegold-Brauer G; Buechel J; Knipprath-Mészaros A; Schoetzau A; Hacker NF; Tercanli S; Lapaire O; Heinzelmann-Schwarz V
    Int J Gynecol Cancer; 2016 Jul; 26(6):1062-9. PubMed ID: 27177281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing benign and malignant pelvic masses: the value of different diagnostic methods in everyday clinical practice.
    Engelen MJ; Bongaerts AH; Sluiter WJ; de Haan HH; Bogchelman DH; Tenvergert EM; Willemse PH; van der Zee AG
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):94-101. PubMed ID: 17118522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of parity to the risk of malignancy index score in evaluating adnexal masses.
    Yavuzcan A; Çağlar M; Özgü E; Üstün Y; Dilbaz S; Ozdemir I; Güngör T; Kumru S
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):518-22. PubMed ID: 25510694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses.
    Morgante G; la Marca A; Ditto A; De Leo V
    Br J Obstet Gynaecol; 1999 Jun; 106(6):524-7. PubMed ID: 10426607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The accuracy of frozen section (intraoperative consultation) in the diagnosis of ovarian masses.
    Ilvan S; Ramazanoglu R; Ulker Akyildiz E; Calay Z; Bese T; Oruc N
    Gynecol Oncol; 2005 May; 97(2):395-9. PubMed ID: 15863135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals.
    Tingulstad S; Hagen B; Skjeldestad FE; Halvorsen T; Nustad K; Onsrud M
    Obstet Gynecol; 1999 Mar; 93(3):448-52. PubMed ID: 10074998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.
    Vaes E; Manchanda R; Autier P; Nir R; Nir D; Bleiberg H; Robert A; Menon U
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):91-8. PubMed ID: 21695741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.